Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by age group
| dc.contributor.author | Hitier, Simon | |
| dc.contributor.author | Basaran, Mert | |
| dc.contributor.author | Matus, Geoffrey | |
| dc.contributor.author | Heidenreich, Axel | |
| dc.contributor.author | Bahl, Amit | |
| dc.contributor.author | Malik, Zafar | |
| dc.contributor.author | di Lorenzo, Giuseppe | |
| dc.contributor.author | Bracarda, Sergio | |
| dc.contributor.author | Ardavanis, Alexandros | |
| dc.contributor.author | Parente, Phillip | |
| dc.contributor.author | de Schultz, Wito | |
| dc.contributor.author | Saad, Fred | |
| dc.contributor.author | van Oort, Inge | |
| dc.contributor.author | Gerritsen, Winald R. | |
| dc.contributor.author | Aparicio, Luis M. Anton | |
| dc.date.accessioned | 2021-03-03T08:07:35Z | |
| dc.date.available | 2021-03-03T08:07:35Z | |
| dc.identifier.citation | Malik Z., di Lorenzo G., Bracarda S., Ardavanis A., Basaran M., Parente P., de Schultz W., Saad F., van Oort I., Gerritsen W. R. , et al., "Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by age group", Genitourinary Cancers Symposium, San-Francisco, Kostarika, 30 Ocak - 01 Şubat 2014, cilt.32 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_15d23144-a22e-4c2c-aa8d-97e64af04ebc | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/20027 | |
| dc.identifier.uri | https://doi.org/10.1200/jco.2014.32.4_suppl.109 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp | |
| dc.subject | ONKOLOJİ | |
| dc.title | Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by age group | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 32 | |
| dc.contributor.firstauthorID | 143717 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]